SOPHIA ANTIPOLIS, France – October 27, 2023 │The GaN newsletter for October 2023 is now available! This monthly newsletter allows you to keep up to date on the latest scientific publications, patent applications, and news related to III-Nitride semiconductors (GaN, AlN, InN, and alloys) for optoelectronic and electronic applications (power, RF, LED, laser, photonics, and[…]
SOPHIA ANTIPOLIS, France – October 25, 2023 │ The quarterly report for the Q3 2023 Therapeutic mRNA patent monitor is now available! This report covers all aspects of mRNA design, delivery, manufacturing, storing, mRNA-based vaccines, and mRNA-based therapeutics. Let’s focus on an aspect of mRNA design that that ended up in a Nobel prize! mRNA[…]
SOPHIA ANTIPOLIS, France – October 10, 2023 │ In the pharmaceutical industry, patents are crucial for companies developing new therapies and conducting clinical trials to assess their effectiveness. Given the time-consuming and expensive process of developing a new drug, patents provide legal protection to the company, guaranteeing a period of exclusivity to sell the medication[…]
SOPHIA ANTIPOLIS, France – September 28, 2023 │Since the FDA approval of two CAR-T cell therapies in 2017, CAR therapy has gained a big interest. Indeed, KYMRIAH™ (tisagenlecleucel) from Novartis and YESCARTA™ (Axicabtagene Ciloleucel) from Kite Pharma, a Gilead company, received the first FDA approval for chimeric antigen receptor (CAR) therapy in 2017. These two[…]